Thomson Reuters Corporation
NASDAQ:TRISpecialty Business Services
-$0.66 today
- Market cap
- $45.04B
- Beta
- 0.18
- P/E (TTM)
- 22.5
- EPS (TTM)
- $3.49
- Dividend yield
- 5.02%
Volume 1.53M
Average 1.98M
TRI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Thomson Reuters CorporationNASDAQ: TRI
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How TRI compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for TRI, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | £352M GBP | -3.3% | +4.4% | 3.7% | |
| LTM Sep 2026 | $184.32M USD | +5.4% | +18.3% | 5.4% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding TRI) | — | +1.0% | +11.4% | 0.0% | |
Competitors are the stored peer set for TRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.35B | 6.63B | 6.79B | 7.26B | 7.48B |
| Cost of Revenue | 1.58B | 1.59B | 1.56B | 1.79B | 1.81B |
| Gross Profit | 4.77B | 5.04B | 5.23B | 5.47B | 5.67B |
| Gross Margin | 75.1% | 76.1% | 77.0% | 75.3% | 75.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 2.75B | 2.67B | 2.53B | 2.66B | 2.72B |
| Operating Expenses | 3.52B | 3.21B | 2.9B | 3.36B | 3.68B |
| Depreciation & Amortization | 770M | 724M | 725M | 822M | 930M |
| EBITDA | 2.03B | 3.01B | 2.95B | 3.05B | 3.05B |
| EBITDA Margin | 31.9% | 45.4% | 43.4% | 42.1% | 40.8% |
| Operating Income | 1.24B | 1.83B | 2.33B | 2.11B | 1.99B |
| Operating Margin | 19.6% | 27.7% | 34.3% | 29.1% | 26.6% |
| Interest Income | 1.98M | 6.72M | 85.54M | 72.35M | 40M |
| Interest Expense | 186.35M | 185.35M | 215.89M | 168.5M | 183M |
| Other Income / Expenses | 6.05B | (184M) | 731M | (40M) | (83M) |
| Income Before Tax | 7.29B | 1.65B | 3.06B | 2.07B | 1.91B |
| Pre-Tax Margin | 114.9% | 24.9% | 45.1% | 28.5% | 25.5% |
| Income Tax Expense | 1.61B | 259M | 417M | (123M) | 423M |
| Net Income | 5.69B | 1.34B | 2.7B | 2.21B | 1.5B |
| Net Margin | 89.6% | 20.2% | 39.7% | 30.4% | 20.1% |
| EPS (Basic) | 11.42 | 2.65 | 5.91 | 4.89 | 3.40 |
| EPS (Diluted) | 11.40 | 2.64 | 5.90 | 4.89 | 3.40 |
| Weighted Avg Shares | 493.44M | 483.89M | 463.18M | 450.61M | 448.97M |
| Weighted Avg Shares (Diluted) | 494.5M | 484.93M | 463.97M | 451.24M | 449.53M |
Thomson Reuters Corporation
NASDAQ:TRI
Intrinsic Alpha fair value
Locked
Current Price
$103.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.